These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ocular melanosis with special reference to chlorpromazine. Cameron ME Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771 [No Abstract] [Full Text] [Related]
5. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
6. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
7. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy. Baron JB; Rivoalan Y; Morel P Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348 [No Abstract] [Full Text] [Related]
8. Melanosis after prolonged chlorpromazine therapy. Robins AH S Afr Med J; 1975 Aug; 49(37):1521-4. PubMed ID: 1162531 [TBL] [Abstract][Full Text] [Related]
9. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series. Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147 [TBL] [Abstract][Full Text] [Related]
18. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine. Gualtieri CT; Lefler WH; Guimond M; Staye JI Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312 [TBL] [Abstract][Full Text] [Related]
19. [Ocular complications in long-term chlorpromazine treatment]. Klíma M; Klímová A Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908 [No Abstract] [Full Text] [Related]